AMD updated - page 176

176
therapy in neovascular age-related macular degeneration (FO-
CUS): year 2 results. Am J Ophthalmol 2008; 145 (5): 862-74.
20. MONT BLANC Study Results. 17th Congress of the European Soci-
ety of Ophthalmology, 2009, Amsterdam, the Netherlands.
21. Schmidt-Erfurth U, Kiss C, Sacu S. The role of choroidal hypoper-
fusion associated with photodynamic therapy in neovascular age-
related macular degeneration and the consequences for combination
strategies. Prog Retin Eye Res 2009; 28 (2): 145-54.
22. Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R,
Lashay A, Azarmina M, Dehghan MH, Moradian S. Single-session
photodynamic therapy combined with intravitreal bevacizumab and
triamcinolone for neovascular age-related macular degeneration. BMC
Ophthalmol 2007; 7:10.
23. Augustin AJ, Puls S, Offermann I. Triple therapy for choroidal
neovascularization due to age-related macular degeneration: verte-
porfin PDT, bevacizumab, and dexamethasone. Retina 2007; 27
(2): 133-40.
24. Liggett PE, Colina J, Chaudhry NA, Tom D, Haffner G. Triple
therapy of intravitreal triamcinolone, photodynamic therapy, and
pegaptanib sodium for choroidal neovascularization. Am J Oph-
thalmol 2006; 142 (6): 1072-4.
25. Silva RM, Cachulo ML, Figueira J, de Abreu JR, Cunha-Vaz JG.
Chorioretinal anastomosis and photodynamic therapy: a two-year
follow-up study. Graefes Arch Clin Exp Ophthalmol 2007; 245
(8): 1131-9.
26. Silva RM, Faria de Abreu JR, Travassos A, Cunha-Vaz JG. Stabi-
lization of visual acuity with photodynamic therapy in eyes with
chorioretinal anastomoses. Graefes Arch Clin Exp Ophthalmol
2004; 242 (5): 368-76.
1...,166,167,168,169,170,171,172,173,174,175 177,178,179,180,181,182,183,184,185,186,...258
Powered by FlippingBook